Which amphetamine-type stimulants can be detected by oral fluid immunoassays?

Therapeutic Drug Monitoring

Volumn 34, Issue 1, 2012, Pages 98-109

  Souza, Daniele Z ^a,b   Boehl, Paula O ^b   Comiran, Eloisa ^b   Prusch, Débora S ^b   Zancanaro, Ivomar ^b   Fuentefria, Alexandre M ^b   Pechansky, Flavio ^b   Duarte, Paulina C A V ^c   De Boni, Raquel B ^b   Fröehlich, Pedro E ^b   Limberger, Renata P ^b  

^a Rio Grande do Sul Technical and Scientific Division   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c National Secretariat for Drug Policies (SENAD)   (Brazil)

Author keywords

amphetamine type stimulants; immunoassays; oral fluid

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMFEPRAMONE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; AMPHETAMINE TYPE STIMULANT; BENZPHETAMINE; CLOBENZOREX; FENPROPOREX; METHAMPHETAMINE; METHYLPHENIDATE; OXEDRINE; PHENDIMETRAZINE; PHENYLEPHRINE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG;

ATTENTION DEFICIT DISORDER; DRUG DETERMINATION; DRUG LEGISLATION; DRUG MARKETING; DRUG MONITORING; DRUG STRUCTURE; DRUG TRAFFIC; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; NARCOLEPSY; ORAL FLUID IMMUNOASSAY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 84856173109     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31823d8e8d     Document Type: Review

References (112)

1. Bernhoft IM, Steentoft A, Johansen SS, et al. Drugs in injured drivers in Denmark. Forensic Sci Int. 2005;150:181e189.
2. Wylie FM, Torrance H, Seymour A, et al. Drugs in oral fluid. Part II. Investigation of drugs in drivers. Forensic Sci Int. 2005;150:199e204.
3. Giovanardi D, Castellana CN, Pisa S, et al. Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy. Drug Alcohol Depend. 2005;80:135e138.
4. Davey J, Freeman J, Lavelle A. Screening for drugs in oral fluid: Illicit drug use and drug driving in a sample of urban and regional Queensland motorists. Transp Res Part F. 2009;12:311e316.
5. Labat L, Fontaine B, Delzenne C, et al. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de Calais region (France). Forensic Sci Int. 2008;174:90e94.
6. Gjerde H, Normann PT, Pettersen BS, et al. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: A roadside survey. Accid Anal Prev. 2008;40:1765e1772.
7. Silva OA, Greve JMD, Yonamine M, et al. Drug use by truck drivers in Brazil. Drugs Educ Prev Policy. 2003;10:135e139.
8. Souza JC, Paiva T, Reimao R. Sleep habits, sleepiness and accidents among truck drivers. Arq Neuropsiquiatr. 2005;63:925e930.
9. Couper FJ, Pemberton M, Jarvis A, et al. Prevalence of drug use in commercial tractor-trailer drivers. J Forensic Sci. 2002;47:562e567.
10. Williamson A. Predictors of psychostimulant use by long-distance truck drivers. Am J Epidemiol. 2007;166:1320e1326.
11. Mabbott NA, Hartley LR. Patterns of stimulant drug use on Western Australian heavy transport routes. Transp Res Part F. 1999;2:115e130.
12. World Health Organization (WHO). Management of substance abuse-Amphetamine-type stimulants. Available at: Http://www.who.int/substance- Abuse/facts/ATS/en/index.html. Accessed July 2011.
13. Kintz P, Samyn N. Use of alternative specimens: Drugs of abuse in saliva and doping agents in hair. Ther Drug Monit. 2002;24:239e246.
14. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2006;27: 147e159.
15. Gjerde H, Verstraete A. Can the prevalence of high blood drug concentrations in a population be estimated by analysing oral fluid? A study of tetrahydrocannabinol and amphetamine. Forensic Sci Int. 2010; 195:153e159.
16. Samyn N, De Boeck G, Verstraete AG. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J Forensic Sci. 2002; 47:1380e1387.
17. Biermann T, Schwarze B, Zedler B, et al. On-site testing of illicit drugs: The use of the drug-testing device "Toxiquick". Forensic Sci Int. 2004;143: 21e25.
18. Pehrsson A, Gunnar T, Engblom C, et al. Roadside oral fluid testing: Comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008;175:140e148.
19. Toennes SW, Kauert GF, Steinmeyer S, et al. Driving under the influence of drugs-evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152:149e155.
20. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci. 2007;1098:51e103.
21. Grönholm M, Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci Int. 2001;121: 37e46.
22. Behrensdorff I, Steentoft A. Medicinal and illegal drugs among Danish car drivers. Accid Anal Prev. 2003;35:851e860.
23. Dot HS 810 704: Pilot test of new roadside survey methodology for impaired driving (National Highway Traffic Safety Administration-NHTSA Web site). Washington, WA: 2007. Available at: Http:// www.nhtsa.gov/DOT/NHTSA/ Traffic%20Injury%20Control/Articles/ Associated%20Files/PilotTestreg;NRSM.pdf. Accessed August 2010.
24. Wille SM, Samyn N, Ramírez-Fernández Mdel M, et al. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Forensic Sci Int. 2010;198:2e6.
25. Concheiro M, de Castro A, Quintela O, et al. Confirmation by LCeMS of drugs in oral fluid obtained from roadside testing. Forensic Sci Int. 2007;170:156e162.
26. Drummer OH, Gerostamoulos D, Chu M, et al. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int. 2007;170:105e110.
27. Random roadside drug testing (Arrive Alive Web site). Available at: Http://www.arrivealive.vic.gov.au/initiatives/safer-road-users/ random-roadside-drug-/random-roadside-drug-testing.html. Accessed July 2010.
28. Australia. Road Safety Act 1986-n. 127/1986, version 123-Incorporating amendments as at July 1, 2010 (Victorian Legislation Web site). Available at: Http://www.legislation.vic.gov.au/domino/Web-Notes/ LDMS/LTObject-Store/ LTObjSt5.nsf/DDE300B846EED9C7CA2576 16000A3571/E880E03FD3734AC7CA2578010010E623/ FILE/86-127a127.pdf. Accessed July 2010.
29. Australia. Road Safety (General) Regulations 2009-n.115/2009, version 003-Incorporating amendments as at July 1, 2010 (Victorian Legislation Web site). Available at: Http://www.legislation.vic.gov.au/Domino/Web-Notes/LDMS/ LTObject-Store/LTObjSt5.nsf/DDE300B846EED9C7CA2 57616000A3571/ 593D8EAD6D15D717CA2577ED007A6C84/FILE/09-115sr005.pdf. Accessed July 2010.
30. Butler M. Australia's approach to drugs and driving, of Subst. (of substance web site). Available at: Http://www.ofsubstance.org.au/ images/archive/pdf/ofsubstance-2007-7.pdf. Accessed July 2010.
31. Portugal, Lei n° 18 de 17 de maio de 2007, Aprova o Regulamento de Fiscalizacxao da Conducxao sob influência do álcool ou de substâncias psicotró picas (Diário da República electronico web site). Available at: Http://dre.pt/pdfgratis/2007/05/09500.pdf. Accessed July 2010.
32. Portugal, Autoridade Nacional de Segurancxa Rodoviária, Despacho n° 20692/2007, Aprovacxao dos equipamentos a utilizar nos testes de rastreio na saliva (ANSR web site). Available at: Http://www.ansr.pt/ LinkClick.aspx?fileticket=86AvTidFJVc%3d&tabid=74&mid=382&language= pt-PT.pdf. Accessed July 2010.
33. Portugal, Autoridade Nacional de Segurancxa Rodoviária, Despacho n° 21240/2008, Aprovacxao dos equipamentos a utilizar nos testes de rastreio na saliva (ANSR Web site). Available at: Http://www.ansr.pt/ LinkClick.aspx?fileticket=IoNoQUKkXpc%3d&tabid=74&mid=382&language= pt-PT.pdf. Accessed July 2010.
34. Portugal, Autoridade Nacional de Segurancxa Rodoviária, Despacho n° 28663/2008, Aprovacxao dos equipamentos a utilizar nos testes de rastreio na saliva (ANSR Web site). Available at: Http://www.dre.pt/ pdf2s/2008/11/217000000/4588845888.pdf. Accessed July 2010.
35. Portugal, Autoridade Nacional de Segurancxa Rodoviária, Despacho n° 29524/2008, Aprovacxao de equipamento a utilizar nos testes de rastreio na saliva (ANSR web site). Available at: Http://www.ansr.pt/LinkClick. aspx?fileticket=XTuuTYRyTeE%3d&tabid=74&mid=382&language=pt-PT.pdf. Accessed July 2010.
36. Portugal, Autoridade Nacional de Segurancxa Rodoviária, Despacho n° 13228/2009, Aprovacxao dos equipamentos a utilizar nos testes de rastreio na saliva (ANSR web site). Available at: Http://www.prociv.pt/ Legislacao/Documents/Desp-13226-2009-Medalha.pdf. Accessed July 2010.
37. Amphetamine Elisa kit for oral fluids [package insert]. Version 10/2005. Pomona, CA: Immunalysis Corporation; 2005.
38. Methamphetamine Elisa kit for oral fluids [package insert]. Version 09/ 2005. Pomona, CA: Immunalysis Corporation; 2005.
39. Oral-ViewTM saliva multi-drug of abuse test [package insert]. Revision E 030409. Poway, CA: Alfa Scientific Designs, 2009.
40. United Nations International Drug Control Programme. Recommended Methods for the Detection and Assay of Heroin, Cannabinoids, Cocaine, Amphetamine, Methamphetamine and Ring-Substituted AmphetamineDerivatives in Biological Specimens. New York, NY: United Nations; 1995.
41. Verstraete AG, Raes E, eds. Rosita-2 project: Final report (EU-Project ROSITA web site). Gent, Belgium: Academia Press; 2006. Available at: Http://www.rosita.org. Accessed July 2010.
42. Verstraete AG. Oral fluid testing for driving under the influence of drugs: History, recent progress and remaining challenges. Forensic Sci Int. 2005; 150:143e150.
43. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2010. New York, NY: United Nations; 2010.
44. Drugwipe® Technical Specifications (technical specifications). Williamsport, PA: Securetec; 2010. Available at: Http://www.affiniton.com/ drugwipeInserts.pdf. Accessed August 2010.
45. Cozart® DDS 806 Drug Detection System CGP7189 (technical specifications). Oxfordshire: Concateno plc; 2010. Available at: Http:// www.concateno.com/ddme-cms/userfiles/files/technical-specifications/ CGP7189%20Cozart%20DDS%20806%20Technical%20Specification% 2014JUL09.pdf. Accessed August 2010.
46. Dräger DrugTestreg; 5000 test kit: Product information (Dräger Safety AG & Co. KGaA web site). Lübeck, Germany: Dräger Safety AG & Co. KGaA; 2010. Available at: Http://www.draeger.com/media/10/08/91/ 10089102/cdi-drugtest-5000-test-kits2-bro-us.pdf. Accessed August 2010.
47. Dräger DrugTestreg; 5000-cross reactivity chart (technical information sent by the manufacturer). Lübeck, Germany: Dräger Safety AG & Co. KGaA; 2010.
48. Dräger DrugCheckTM specificity study summary and Dräger Drug-CheckTM cross reactivity study summary (technical information sent by the manufacturer). Lübeck, Germany: Dräger Safety AG & Co. KGaA. 2005.
49. Oratect® III oral fluid drug screen device ME/TH/CO/AM/OP/PC or BZ-catalog no. HM11 and HM12 (technical information sent by the manufacturer). Irvine, CA: Branan Medical Corporation; 2009.
50. Cooper G,Wilson L, Reid C, et al. Validation of the Cozart amphetamine microplate EIA for the analysis of amphetamines in oral fluid. Forensic Sci Int. 2006;159:104e112.
51. Blencowe T, Pehrsson A, Lillsunde P, eds. Analytical evaluation of oral fluid screening devices and preceding selection procedures (DRUIDproject web site). Available at: Http://www.druid-project.eu/nn-107548/ Druid/EN/ deliverales-list/downloads/Deliverable-3-2-2,templateId=raw,property= publicationFile.pdf/Deliverable-3-2-2.pdf. Accessed March 2010.
52. Melo JMS, ed.Dicioná rio de Especialidades Farmacêuticas-DEF 2009/10. 35th ed. Rio de Janeiro, Brazil: Publicacxoes Científicas; 2009.
53. Korolkovas A, Francxa FFAC.Dicioná rio Terapêutico Guanabara. 16th ed. Rio de Janeiro, Brazil: Guanabara Koogan; 2009.
54. Vademécum PR. Online (P.R. Vademecum online web site). Available at: Http://www.prvademecum.com/pantalla-paises.asp. Accessed July 2010.
55. Chile. Productos com Registro (database online). Available at: Http:// 200.68.11.21/RegistrosISP/fimenu.asp. Accessed July 2010.
56. Peru. Registro Sanitario de Productos Farmaceuticos (database online). Available at: Http://www.digemid.minsa.gob.pe/aplicaciones/Perudis/ INDEX.ASP. Accessed July 2010.
57. Mexico. Registro Sanitario de Medicamentos (database online). Available at: Http://www.cofepris.gob.mx/wb/cfp/medicamentos-Alopaticos. Accessed July 2010.
58. United States. National Drug Code Directory (database online). Available at: Http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438. htm. Accessed July 2010.
59. Medline Plus: Drug information (database online). Available at: Http:// www.nlm.nih.gov/medlineplus/druginformation.html. Accessed July 2010.
60. DailyMed: Current information medication (database online). Available at: Http://dailymed.nlm.nih.gov/dailymed/about.cfm. Accessed July 2010.
61. Canada. Drug product database (database online). Available at: Http:// webprod.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp. Accessed July 2010.
62. Spain. Centro de Información On-line de Medicamentos (database online). Available at: Http://www.aemps.es/. Accessed July 2010.
63. Portugal. Medicamentos de Uso Humano autorizados em Portugal (database online). Available at: Http://www.infarmed.pt/infomed/pesquisa.php. Accessed July 2010.
64. Italy. Elenco farmaci autorizzati (database online). Available at: Http:// farmaco.agenziafarmaco.it/index.php. Accessed July 2010.
65. France. Répertoire des Spécialités Pharmaceutiques (database online). Available at: Http://afssaps-prd.afssaps.fr/php/ecodex/index. php. Accessed July 2010.
66. Germany. Arzneimittel: AMIS-Öffentlicher Teil (database online). Available at: Https://portal.dimdi.de/websearch/servlet/Gate?accessid= freeSelectDe#-DEFANCHOR. Accessed July 2010.
67. United Kingdom. Electronic Medicines Compendium (eMC) (database online). Available at: Http://emc.medicines.org.uk/browseingredients. aspx. Accessed July 2010.
68. Netherlands. Geneesmiddelen Informatiebank Voor Mensen (database online). Available at: Http://www.cbg-meb.nl/CBG/nl/humanegeneesmiddelen/ geneesmiddeleninformatiebank. Accessed July 2010.
69. Belgium. Répertoire Commenté des Médicaments- Février 2010 (database online). Available at: Http://www.cbip.be/. Accessed July 2010.
70. Denmark. Produktresuméer. Available at: Http:// laegemiddelstyrelsen.dk/ da/servicemenu/produktinformation/produktresumeer. Accessed July 2010.
71. Austria. Online Suche Arzneispezialitäten (database online). Available at: Http://pharmaweb.ages.at/pharma-web/index.jsf. Accessed July 2010.
72. Finland. NanWeb haku (database online). Available at: Http://namweb. nam.fi/namweb/do/haku/view. Accessed July 2010.
73. Norway. Søkebase for legemidler (database online). Available at: Http:// www.legemiddelverket.no/custom/Preparatsok/prepSearch-80333. aspx?main. Accessed July 2010.
74. Australia. ARTG current medicines (database online). Available at: Https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuMedicines? OpenView. Accessed July 2010.
75. International Narcotics Control Board (INCB). Report 2009. New York, NY: United Nations; 2010.
76. Sistema Criminalística (database online). Brazil: Polícia Federal; 2010.
77. Hand C, Baldwin D. Immunoassays. In: Moffat AC, Osselton MD, Widdop B, eds. Clarke's Analysis of Drug and Poisons. 3rd ed. London, United Kingdom: Pharmaceutical Press; 2004:301e312.
78. Standards Australia.AS 4760-2006 Procedures for Specimen Collection and the Detection and Quantification of Drugs in Oral Fluid. Sydney, Australia: Standards Australia; 2006.
79. Jirovskú D, Lemr K, Sevćik J, et al. Methamphetamine- properties and analytical methods of enantiomer determination. Forensic Sci Int. 1998; 96:61e70.
80. Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res Rev. 2009;60:379e407.
81. Verschraagen M, Maes A, Ruiter B, et al. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases. Forensic Sci Int. 2007;170:163e170.
82. Schepis TS, Marlowe DB, Forman RF. The availability and portrayal of stimulants over the Internet. J Adolesc Health. 2008;42:458e465.
83. Ghodse H. Uppers keep going up. Br J Psychiatry. 2007;191:279e281.
84. List of psychotropic substances under international control-Green List, Annex to the Annual Statistical Report. 23rd ed. Vienna, Austria: United Nations; 2003 (International Narcotics Control Board-INCBWeb site). Available at http://www.incb.org/pdf/e/list/green.pdf. Accessed August 2010.
85. Convention on psychotropic substances. Vienna, Austria: United Nations; 1971 (International Narcotics Control Board-INCB Web site). Available at http://www.incb.org/pdf/e/conv/convention.1971-en.pdf. Accessed August 2010.
86. Information and legal Resources: Presentations, pharmaceutical trends and updates-National Association of Boards of Pharmacy May 2009 (Drug Enforcement Administration-Office of Diversion Control web site). Available at: Http://www.deadiversion.usdoj.gov/pubs/presentations. Accessed May 2010.
87. Wang SM, Wang TC, Giang YS. Simultaneous determination of amphetamine and methamphetamine enantiomers in urine by simultaneous liquideliquid extraction and diastereomeric derivatization followed by gas chromatographic-isotope dilution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;816:131e143.
88. Kraemer T, Maurer HH. Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine. J Chromatogr B Biomed Sci Appl. 1998;713:163e187.
89. Kraemer T, Maurer HH. Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-Alkyl derivatives. Ther Drug Monit. 2002;24:277e289.
90. Kankaanpää A, Gunnar T, Ariniemi K, et al. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;810:57e68.
91. De la Torre R, Farré M, Navarro M, et al. Clinical pharmacokinetics of amfetamine and related substances: Monitoring in conventional and nonconventional matrices. Clin Pharmacokinet. 2004;43:157e185.
92. Yonamine M. A saliva como espécime biológico para monitorar o uso de álcool, anfetamina, metanfetamina, cocáina e maconha por motoristas profissionais (in Brazil; habilitation thesis). Sao Paulo, Brazil: Universidade de Sao Paulo, 2004 (USP web site). Available at: Http:// www.teses.usp.br/teses/disponiveis/9/9141/tde-03072008-093347/publico/ MauricioYonamine-tese.pdf. Accessed August 2010.
93. Silva OA, Yonamine M. Drug abuse among workers in Brazilian regions. Rev Saude Publica. 2004;38:552e556.
94. Noto AR, Carlini EA, Mastroianni PC, et al. Analysis of prescription and dispensation of psychotropic medications in two cities in the State of Sao Paulo, Brazil. Rev Bras Psiquiatr. 2002;24:68e73.
95. Carneiro MFG, Guerra AA Jr, Acurcio FA. Prescricxao, dispensacxao e regulacxao do consumo de psicotrópicos anorexígenos em Belo Horizonte, Minas Gerais, Brazil. Cad Saúde Pública. 2008;24:1763e1772.
96. Nascimento EC, Nascimento E, Silva JP. Uso de álcool e anfetaminas entre caminhoneiros de estrada. Rev Saúde Pública. 2007;41:290e293.
97. Wendler EA, Busato CR, Miyoshi E. Uso de anfetaminas por motoristas de caminhao para reduzir o sono. Publ UEPG Ci Biol Saude. 2003;9: 7e14.
98. Moreira RS, Gadani JAAB. A prevalência do uso de anfetaminas por caminhoneiros que passam pela cidade de Dourados-MS. Interbio. 2009; 3:27e34.
99. Brazil. Lei n°. 9.503 de 23 de setembro de 1997-Institui o Código Brasileiro de Trânsito (Presidência da República Federativa do Brasil Web site). Available at: Http://www.planalto.gov.br/ccivil/leis/L9503. htm. Accessed May 2010.
100. Walsh JM. New technology and new initiatives in U.S. workplace testing. Forensic Sci Int. 2008;174:120e124.
101. Bell RR, Crookham SB, Dunn WA, et al. A contemporaneous finding of fenproporex in a polydrug suicide. J Anal Toxicol. 2001;25:652e656.
102. Nguyen MH, Ormiston T, Kurani S, et al. Amphetamine lacing of an Internet-marketed neutraceutical. Mayo Clin Proc. 2006;81:1627e1629.
103. Cohen PA. Imported fenproporex-based diet pills from Brazil: A report of two cases. J Gen Intern Med. 2009;24:430e433.
104. Adams K, Smith L, Hind N. Drug driving among police detainees in Australia (Australian Institute of Criminology web site). 2008;357. Available at http://www.aic.gov.au/documents/0/4/F/%7B04FADF29-0514-4F72-BD4F- 773EAD6029A7%7Dtandi357.pdf. Accessed August 2010.
105. Drummer OH, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int. 2003; 134:154e162.
106. United Nations Office on Drugs and Crime. Recommended Methods for the Identification and Analysis of Amphetamine, Methamphetamine and Their Ring-Substituted Analogues in Seized Materials. New York, NY: United Nations; 2006.
107. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biological. 13th ed. Whitehouse Station, NJ: Merck & Co; 2001.
108. Cody JT, Valtier S. Detection of amphetamine following administration of fenproporex. J Anal Toxicol. 1996 ;20:425e431.
109. Kraemer T, Pflugmann T, Bossmann M, et al. Fenproporex N-dealkylation to amphetamineeenantioselective in vitro studies in human liver microsomes aswell as enantioselective in vivo studies inWistar and Dark Agouti rats. Biochem Pharmacol. 2004;68:947e957.
110. Baden KL, Valtier S, Cody JT. Metabolic production of amphetamine following multidose administration of clobenzorex. J Anal Toxicol. 1999;23:511e517.
111. Walsh JM, Verstraete AG, Huestis MA, et al. Guidelines for research on drugged driving. Addiction. 2008;103:1258e1268.
112. Technical Report TR-03-2008: Oral fluid testing devices-validation of selected commercial products for future roadside screening for drugs. (Defence Research and Development Canada web site). Ottawa, Canada: Canadian Police Research Centre, 2008. Available at http:// www.css.drdc-rddc.gc.ca/cprc/tr/tr- 2008-03.pdf. Accessed July 2010